Monday, March 09, 2015
Doubling Down
BREAKING: Kythera Biopharmaceuticals Inc. said Monday that a U.S. Food and Drug Administration advisory panel voted unanimously to recommend approval of the company's injectible drug to treat submental fat in adults, more commonly referred to as a double chin.
Read HERE.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment